<prompt> Baricitinib was approved by FDA recently forOsteo ahritisR ahritisCl difficaleGout  <response>: barcitinib is a janus kinase inhibitoe JAK . Ihibits the activity of JAK 1 and JAK 2 enzymes interfering with JAK STAT pathway. 